If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

My doctoral programme concerns the immune cells that infiltrate tumours which are the basis of immunotherapy, a relatively new set of very powerful cancer treatments. Immunotherapy could allow better cancer treatment by exploiting the ability of certain immune cells to identify and eliminate undesirable cells such as cancer cells. I aim to provide new insights into the genetic traits of the tumour-infiltrating cells and tumours to look for potential new druggable targets using the Oxford Nanopore sequencing technology.

Education/Academic qualification

Medicine, Doctor of Medicine, Università degli Studi di Trieste

1 Oct 201026 Jul 2016

Medical Biotechology, Master of Biology, Università degli Studi di Trieste

Oct 2007Apr 2010

Biotechnology, Bachelor of Science, Università degli Studi di Trieste

Oct 2003Jul 2007

External positions

Medical Advisor, RNA Diagnostics

Mar 2018 → …


  • Tumour Microenvironment
  • Immunotherapy
  • Oncoimmunology
  • Nanoporesequencing
  • MinION
  • Immunology

Fingerprint Dive into the research topics where Alberto D'Angelo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

An overview of the clinical use of cabozantinib in the treatment of advanced non-clear-cell renal cell carcinoma (NCCRCC)

D'Angelo, A., Bagby, S., Di Pierro, G., Chirra, M., Nobili, S., Mini, E., Villari, D. & Roviello, G., 3 Mar 2020, In : Critical Reviews in Oncology/Hematology. 149, 102921.

Research output: Contribution to journalReview article

Immune Checkpoint Inhibitors in Pre-Treated Gastric Cancer Patients: Results from a Literature-Based Meta-Analysis

Roviello, G., Corona, S. P., D'Angelo, A., Rosellini, P., Nobili, S. & Mini, E., 10 Jan 2020, In : International Journal of Molecular Sciences. 21, 2, 448.

Research output: Contribution to journalArticle

Open Access

Avelumab in gastric cancer

Roviello, G., D'Angelo, A., Generali, D., Pittacolo, M., Ganzinelli, M., Iezzi, G., Manzini, N. D. & Sobhani, N., 16 May 2019, In : Immunotherapy. 11, 9, p. 759-768 10 p.

Research output: Contribution to journalArticle

Corticosteroid switch after progression on abiraterone acetate plus prednisone

Roviello, G., Sobhani, N., Corona, S. P. & D'Angelo, A., 8 Nov 2019, In : International Journal of Clinical Oncology. 7 p.

Research output: Contribution to journalReview article

Novel Agents in Heavily Pretreated Metastatic Gastric Cancer: More Shadows Than Lights

Roviello, G., D'Angelo, A., Roudi, R., Petrioli, R. & Mini, E., 4 Jul 2019, In : Journal of oncology. 2019, 9 p., 5692317.

Research output: Contribution to journalReview article

Open Access
1 Citation (Scopus)